Contemporary OB/GYN week in review: abortion bans, HPV vaccination, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: abortion bans, COVID-19 vaccination, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, January 15 - Friday, January 19, 2023), and click each link to read and watch anything you may have missed.
1.) The impact of abortion bans on physician and patient health
A recent study revealed negative impacts of practicing in a state with abortion care restrictions, leading to delayed care, worry over legal repercussions, and adverse mental health outcomes.
Click here for the full article.
2.) Unmet needs in HPV vaccination strategies
A comprehensive review highlighted challenges and research gaps in human papillomavirus vaccination, emphasizing the importance of targeted interventions and effective delivery strategies.
Click here for the full article.
3.) Study reveals disparities in breastfeeding support based on disability
A recent study using the Pregnancy Risk Assessment Monitoring System highlighted lower rates of breastfeeding initiation and duration among women with disabilities, emphasizing the need for targeted interventions to improve breastfeeding outcomes.
Click here for the full article.
4.) Racial and ethnic disparities found in gynecologic oncology clinical trial enrollment
A recent study revealed disparities in gynecologic oncology clinical trial enrollment, impacting the outcomes of underrepresented racial and ethnic groups.
Click here for the full article.
5.) Unveiling the link between financial strain and lower urinary tract symptoms
A recent exposed the relationship between financial strain, underutilization of health care, and comorbidities, shedding light on the heightened risks.
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
